FAQs with Key Opinion Leader - Tanguy Seiwert, MD
Dr. Jan B. Vermorken | Netherlands
Join Jan B. Vermorken, MD, PhD as he shares some of the exciting updates on Squamous Cell Cancer of the Head & Neck (SCCHN)
Dr. Dominik Modest | Germany
Join Dr. Dominik Modest from the Hospital of the University of Munich, Germany, for his presentation, Choice of First-line Therapy in Metastatic Colorectal Cancer. This video was filmed live at the 17th National Congress of the Oncology Group of Southern Italy (GOIM: Gruppo Oncologico Medidionale), held in Bari, Italy, on 15-17 June 2015.
Joël Guigay, MD, PhD | France
We sat down with Dr. Joël Guigay at the 2015 ECC conference in Vienna, Austria, where we discussed the emerging advances in induction and maintenance therapy in head and neck cancer.
Jan B. Vermorken, MD, PhD | Belgium
Dr. Jan B. Vermorken provides his perspective on the recent and emerging advances in induction and maintenance therapy in head and neck cancer. He also discusses current studies related to the treatment of patients who are HPV-positive and HPV-negative and the future advances in those areas.
FAQs with Key Opinion Leader - Athanassios Argiris, MD, PhD, FACP
The Role of Cetuximab Maintenance Therapy after Treatment of SCC Head and Neck Cancer
Makoto Tahara, MD, PhD presents a patient case study on the management of a 40-year old female gingiva cancer patient.
Head and Neck Cancer: Updates from ASCO 2016
Joël Guigay, MD, PhD shares some of the exciting studies presented at ASCO 2016 in Chicago, IL, USA, focusing on locally-advanced head and neck cancer, as well as recurrent/metastatic head and neck cancer.
Makoto Tahara, MD, PhD | Japan
While at the 2015 ECC conference in Vienna, Austria, Dr. Makoto Tahara spoke with us about what he thought were the best presentations and posters from the conference, and what was emerging in induction therapy and maintenance in head and neck cancer. We also discussed what is on the horizon for biomarkers and treating HPV and non-HPV related cancers of the head and neck.